The Príncipe de Asturias University Hospital, in Alcalá de Henares, has gathered around fifty specialists from all over Spain for its 28th Hepatobiliopancreatic Surgery Meeting to discuss the latest advances in the surgical treatment of this tumour.
Pancreatic cancer, one of the tumours with the worst prognosis, was the focus of attention last Thursday for 50 healthcare professionals who came from across Spain. They met at the Príncipe de Asturias University Hospital, in Alcalá de Henares, with a clear objective: to analyse how surgery has evolved from a high-mortality procedure to a standardised intervention that determines the patient's prognosis.
From the Past to the Future of Pancreatic Surgery
The event, organised by the General and Digestive Surgery Service of the Alcalá hospital, was structured into three panels. The first reviewed the evolution of clinical guidelines and highlighted that technical standardisation has been key to reducing mortality. The panel also addressed adjuvance, the pharmacological treatment following surgery.
In the second panel, dedicated to the present, experts focused on minimally invasive and robotic surgery. These techniques allow for more precise interventions and faster recovery. Additionally, the importance of multimodal rehabilitation was emphasised: ensuring that the patient arrives in the best possible condition for both surgery and chemotherapy.
“Neoadjuvance — treatment before surgery — and new drugs targeting genetic alterations are changing the landscape,” hospital sources noted.
AI and 3D Models: The Future is Here
The third panel looked ahead. Artificial intelligence and 3D models are transforming the surgical approach. Algorithms capable of predicting tumour aggressiveness, techniques for venous and arterial reconstruction for locally advanced tumours, and even semi-autonomous surgery guided by fluorescence to identify tumour margins were presented.
For the residents of Alcalá and the Henares Corridor, hosting this meeting at the Príncipe de Asturias Hospital represents a boost to healthcare excellence in the area. The centre, which is already a national reference in hepatobiliopancreatic surgery, reinforces its role as a hub of innovation without the need to travel to the capital.
With 28 editions behind it, this event has established itself as an essential forum for specialists. The combination of cutting-edge surgery and personalised treatments is managing to increase patient survival, something that until recently seemed almost impossible.
The hospital is already working on the next edition, which promises to continue unveiling the advances that are rewriting the history of this disease.
You may also like
